SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TCM informs about outcome of board meeting

11 Nov 2025 Evaluate
TCM has informed that the Board of Directors of the Company in its meeting held on Tuesday, 11th November, 2025 has considered and approved the following business: The Consolidated and Standalone Unaudited Financial Results of the Company along with the Consolidated and Standalone Limited Review Reports for the Quarter ended 30th September 2025. The meeting commenced at 10.30 AM and concluded at 12:00 PM. Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, they are enclosing the Unaudited Standalone and Consolidated Financial Results for the first quarter ended 30th September 2025 along with a copy of Limited Review Reports issued by the Auditors of the Company. 

The above information is a part of company’s filings submitted to BSE.

TCM Share Price

43.35 0.06 (0.14%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4035.90
Tata Chemicals 782.10
SRF 2780.75
Pidilite Inds. 1476.15
Deepak Nitrite 1875.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×